COMMUNIQUÉS West-GlobeNewswire

-
Abattis Completes Investment in XLABS Therapeutics to Launch New Cannabis Lab in Ontario
25/07/2018 -
Psychemedics Announces 2Q Record Revenues
24/07/2018 -
Assure Holdings Corp. Announces Update
24/07/2018 -
N.M. Medical Cannabis Program Surging Toward $100 Million in 2018
24/07/2018 -
BioDelivery Sciences to Report Second-Quarter 2018 Financial Results on August 9, 2018
24/07/2018 -
BeiGene Initiates Phase 3 Pivotal Trial of Anti-PD-1 Antibody Tislelizumab Combined with Chemotherapy as First-Line Treatment for Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer in China
24/07/2018 -
Radius Health Provides Update on Appeal of CHMP Opinion for Abaloparatide-SC
24/07/2018 -
Merit Medical Announces Commencement of Public Offering of Common Stock
24/07/2018 -
Kane Biotech Retains Market-Making Services
24/07/2018 -
FDA’s Office of Drug Evaluation III Denies Agile Therapeutics, Inc.’s Initial Formal Dispute Resolution Request
24/07/2018 -
Quotient Limited to Report Fiscal First Quarter 2019 Financial Results and Host Conference Call
24/07/2018 -
argenx announces publication of full data from Phase 1 healthy volunteer study of efgartigimod in Journal of Clinical Investigation
24/07/2018 -
Sientra® to Release Second Quarter 2018 Financial Results on August 7, 2018
24/07/2018 -
Nabriva Therapeutics Strengthens Antibiotics Leadership Position with Acquisition of Zavante Therapeutics
24/07/2018 -
Adverum Biotechnologies Appoints Katherine Bock as Vice President, Investor Relations & Corporate Communications
24/07/2018 -
TRHC Commends Progress to Expand Eligibility for MTM Services under Medicare Part D to Combat Opioid Crisis
24/07/2018 -
Teligent, Inc. Announces FDA Approval of Hydrocortisone Cream USP, 2.5%
24/07/2018 -
CFN Media Podcast -- The U.S. Cannabis Market: New Promise, Persistent Constraints
24/07/2018 -
CORRECTION - CFN Media - CROP Infrastructure Offers More Than Just Greenhouses to Licensed Growers
24/07/2018
Pages